永赢医药创新智选混合发起C(015916)资产负债表
| |
2025-06-30 |
2024-12-31 |
2024-06-30 |
2023-12-31 |
| 资产 |
| 银行存款 |
- |
- |
- |
- |
| 结算备付金 |
6,990,166.80 |
155,592.83 |
477,641.98 |
1,388,268.64 |
| 存出保证金 |
535,632.72 |
97,541.39 |
117,566.57 |
92,104.97 |
| 交易性金融资产 |
2,766,047,503.29 |
163,306,685.30 |
226,747,517.88 |
308,958,764.87 |
| 其中：股票投资 |
2,766,047,503.29 |
158,442,803.60 |
226,542,643.30 |
308,958,764.87 |
| 债券投资 |
- |
4,863,881.70 |
204,874.58 |
- |
| 资产支持证券投资 |
- |
- |
- |
- |
| 衍生金融资产 |
- |
- |
- |
- |
| 买入返售金融资产 |
- |
- |
- |
- |
| 应收证券清算款 |
- |
784,552.22 |
- |
- |
| 应收利息 |
- |
- |
- |
- |
| 应收股利 |
725,441.76 |
- |
171,901.66 |
- |
| 应收申购款 |
82,162,249.65 |
1,107,938.83 |
1,405,784.02 |
17,313,439.68 |
| 其他资产 |
- |
- |
- |
- |
| 资产总计 |
3,402,314,499.54 |
175,893,220.72 |
253,728,540.40 |
348,159,718.51 |
| 负 债 |
| 短期借款 |
- |
- |
- |
- |
| 交易性金融负债 |
- |
- |
- |
- |
| 衍生金融负债 |
- |
- |
- |
- |
| 卖出回购金融资产款 |
- |
- |
- |
- |
| 应付证券清算款 |
28,890,445.60 |
1,200,660.63 |
181,763.40 |
7,999,726.39 |
| 应付赎回款 |
325,294,887.01 |
2,898,118.11 |
7,638,702.78 |
6,247,510.85 |
| 应付管理人报酬 |
2,613,154.83 |
175,081.13 |
244,631.68 |
338,789.26 |
| 应付托管费 |
108,881.44 |
7,295.06 |
10,192.96 |
14,116.22 |
| 应付销售服务费 |
773,504.55 |
49,474.69 |
72,031.31 |
98,358.54 |
| 应付交易费用 |
- |
- |
- |
- |
| 应交税费 |
- |
- |
- |
- |
| 应付利息 |
- |
- |
- |
- |
| 应付利润 |
- |
- |
- |
- |
| 其他负债 |
1,815,512.64 |
259,379.29 |
501,018.97 |
764,419.27 |
| 负债合计 |
359,496,386.07 |
4,590,008.91 |
8,648,341.10 |
15,462,920.53 |
| 所有者权益 |
| 实收基金 |
1,998,173,732.69 |
190,094,508.63 |
291,688,394.09 |
323,399,894.76 |
| 未分配利润 |
1,044,644,380.78 |
-18,791,296.82 |
-46,608,194.79 |
9,296,903.22 |
| 所有者权益合计 |
3,042,818,113.47 |
171,303,211.81 |
245,080,199.30 |
332,696,797.98 |
| 负债及所有者权益总计 |
3,402,314,499.54 |
175,893,220.72 |
253,728,540.40 |
348,159,718.51 |
微信公众号
证券之星APP
基本资料
